A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients

Brief description of study

The THINKER-NEXT research study is being done to determine whether it is safe to give a kidney transplant from a donor with hepatitis C to a patient without hepatitis C. The recipient will then be given a drug called Epclusa for 12 weeks to treat hepatitis C. Patients who are on the kidney transplant waitlist and do not have hepatitis C will be asked to participate.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Hepatitis C,renal
Age: - 99 Years
Gender: All

Updated on 09 Mar 2024. Study ID: 842809

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).